Month's Contracts
25
+10 This month
Total Contracts
125
+12.5% vs LY
Pending Approvals
12
-5.2% vs LM
Total Savings (INR)
38,52,450
+20.1% vs LY
Formulary Products
850
+50 This Year
All Contracts
Manage and track all rate contracts.
MOLECULE | PRODUCT | COMPANY | SUPPLIER | STATUS | MRP | RATE | MARGIN | MARGIN% | GST | MARGIN% INCL. GST | RANK | APPROVED BY | Actions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amlodipine | Amlodipine 5mg | Pfizer | Pharma Co. | Approved | 20.00 | 15.75 | 4.25 | 21.25% | 12% | 11.83% | L1 | Dr. Smith | |
Amlodipine | Amlodipine 10mg | Cipla | Generic Meds | Pending | 22.00 | 18.00 | 4.00 | 18.18% | 12% | 8.93% | L2 | - | |
Lisinopril | Lisinopril 10mg | Novartis | Generic Meds | Pending | 10.00 | 8.50 | 1.50 | 15.00% | 12% | 4.88% | L1 | - | |
Metformin | Metformin 500mg | Merck | Health Solutions | Approved | 15.00 | 12.00 | 3.00 | 20.00% | 5% | 15.87% | L1 | Dr. Jones | |
Atorvastatin | Atorvastatin 20mg | Sun Pharma | Pharma Co. | Rejected | 40.00 | 35.20 | 4.80 | 12.00% | 12% | 0.96% | L1 | Committee |